Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells

Inflammation and iron accumulation are present in a variety of neurodegenerative diseases that include Alzheimer's disease and Parkinson's disease. The study of the putative association between inflammation and iron accumulation in central nervous system cells is relevant to understand the contribution of these processes to the progression of neuronal death. In this study, we analyzed the effects of the inflammatory cytokines tumor necrosis factor alpha (TNF‐α) and interleukin 6 (IL‐6) and of lipopolysaccharide on total cell iron content and on the expression and abundance of the iron transporters divalent metal transporter 1 (DMT1) and Ferroportin 1 (FPN1) in neurons, astrocytes and microglia obtained from rat brain. Considering previous reports indicating that inflammatory stimuli induce the systemic synthesis of the master iron regulator hepcidin, we identified brain cells that produce hepcidin in response to inflammatory stimuli, as well as hepcidin‐target cells. We found that inflammatory stimuli increased the expression of DMT1 in neurons, astrocytes, and microglia. Inflammatory stimuli also induced the expression of hepcidin in astrocytes and microglia, but not in neurons. Incubation with hepcidin decreased the expression of FPN1 in the three cell types. The net result of these changes was increased iron accumulation in neurons and microglia but not in astrocytes. The data presented here establish for the first time a causal association between inflammation and iron accumulation in brain cells, probably promoted by changes in DMT1 and FPN1 expression and mediated in part by hepcidin. This connection may potentially contribute to the progression of neurodegenerative diseases by enhancing iron‐induced oxidative damage.

[1]  P. Riederer,et al.  Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients , 1994, Neuroscience Letters.

[2]  N. Andrews,et al.  Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.

[3]  Y. Ke,et al.  The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes. , 2009, The Journal of nutritional biochemistry.

[4]  C. Piantadosi,et al.  TNF, IFN-gamma, and endotoxin increase expression of DMT1 in bronchial epithelial cells. , 2005, American Journal of Physiology - Lung cellular and Molecular Physiology.

[5]  C. Beaumont,et al.  Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. , 2011, Gastroenterology.

[6]  M. Kruszewski,et al.  Labile iron pool: the main determinant of cellular response to oxidative stress. , 2003, Mutation research.

[7]  Elizabeta Nemeth,et al.  Hepcidin and iron homeostasis. , 2012, Biochimica et biophysica acta.

[8]  Z. Qian,et al.  Role of hepcidin in murine brain iron metabolism , 2009, Cellular and Molecular Life Sciences.

[9]  T. Nagatsu,et al.  Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease , 1996, Neuroscience Letters.

[10]  Joshua A. Smith,et al.  Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases , 2012, Brain Research Bulletin.

[11]  C. Vulpe,et al.  Mammalian iron transport , 2009, Cellular and Molecular Life Sciences.

[12]  S. Hunot,et al.  Neuroinflammatory processes in Parkinson's disease , 2003, Annals of neurology.

[13]  M. Valko,et al.  Importance of iron chelation in free radical-induced oxidative stress and human disease. , 2011, Current pharmaceutical design.

[14]  Minoru Harada,et al.  Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients , 1994, Neuroscience Letters.

[15]  S. Nam,et al.  Inflammation and Alzheimer’s disease , 2010, Archives of pharmacal research.

[16]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[17]  S. Kaech,et al.  Culturing hippocampal neurons , 2006, Nature Protocols.

[18]  P. Riederer,et al.  Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. , 1994, Neuroscience letters.

[19]  C. Piantadosi,et al.  TNF, IFN-γ, and endotoxin increase expression of DMT1 in bronchial epithelial cells , 2005 .

[20]  L. Lue,et al.  Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease , 2001, Neurochemistry International.

[21]  A. A. Farooqui,et al.  Iron, neuroinflammation, and Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[22]  M. Núñez,et al.  Iron toxicity in neurodegeneration , 2012, BioMetals.

[23]  D. Haile,et al.  Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. , 2005, Blood cells, molecules & diseases.

[24]  T. Kielian,et al.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. , 2011, Clinical science.

[25]  Xudong Huang,et al.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. , 2009, Biochimica et biophysica acta.

[26]  P. Riederer,et al.  Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. , 1994, Neuroscience letters.

[27]  T. Nagatsu,et al.  Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. , 1996, Neuroscience letters.

[28]  V. Ganapathy,et al.  Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe. , 2008, The Biochemical journal.

[29]  M. Puliti,et al.  Iron regulates microglial cell-mediated secretory and effector functions. , 1996, Cellular immunology.

[30]  V. Kaushal,et al.  Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra , 2008, The Journal of Neuroscience.

[31]  R. Zivadinov,et al.  Iron deposition and inflammation in multiple sclerosis. Which one comes first? , 2011, BMC Neuroscience.

[32]  A. Kirkwood,et al.  Iron Mediates N-Methyl-d-aspartate Receptor-dependent Stimulation of Calcium-induced Pathways and Hippocampal Synaptic Plasticity* , 2011, The Journal of Biological Chemistry.

[33]  B. Viviani.  Preparation and Coculture of Neurons and Glial Cells , 2006, Current protocols in cell biology.

[34]  A. Redensek,et al.  Iron homeostasis in astrocytes and microglia is differentially regulated by TNF‐α and TGF‐β1 , 2012, Glia.

[35]  Jennifer L. Turi,et al.  Hepcidin expression in human airway epithelial cells is regulated by interferon-γ , 2011, Respiratory research.

[36]  Peter Scheurich,et al.  TNFR1‐induced activation of the classical NF‐κB pathway , 2011, The FEBS journal.

[37]  The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1 , 2012, BioMetals.

[38]  R. von Bernhardi,et al.  Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. , 2012, Antioxidants & redox signaling.

[39]  Prasad N. Paradkar,et al.  Post-translational and transcriptional regulation of DMT1 during P19 embryonic carcinoma cell differentiation by retinoic acid. , 2006, The Biochemical journal.

[40]  Phil Lee,et al.  Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis , 2011, BMC Neuroscience.

[41]  E. Beutler,et al.  Regulation of hepcidin transcription by interleukin-1 and interleukin-6. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Núñez,et al.  Hepcidin inhibits apical iron uptake in intestinal cells. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[43]  Y. Ke,et al.  The iron regulatory hormone hepcidin inhibits expression of iron release as well as iron uptake proteins in J774 cells. , 2012, The Journal of nutritional biochemistry.

[44]  G. Bing,et al.  Inflammation and age-related iron accumulation in F344 rats. , 2008, Current aging science.

[45]  K. Yeh,et al.  Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[46]  O. von Bohlen und Halbach,et al.  Distribution of the iron‐regulating protein hepcidin in the murine central nervous system , 2006, Journal of neuroscience research.

[47]  Peter Riederer,et al.  The relevance of iron in the pathogenesis of Parkinson’s disease , 2011, Journal of neurochemistry.

[48]  B. Todorich,et al.  Cytokine toxicity to oligodendrocyte precursors is mediated by iron , 2005, Glia.

[49]  M. Muckenthaler,et al.  Sustained Submicromolar H2O2 Levels Induce Hepcidin via Signal Transducer and Activator of Transcription 3 (STAT3)* , 2012, The Journal of Biological Chemistry.

[50]  Zhi‐Feng Zhang,et al.  Hepcidin Treatment Modulates the Expression of Divalent Metal Transporter-1, Ceruloplasmin, and Ferroportin-1 in the Rat Cerebral Cortex and Hippocampus , 2011, Biological Trace Element Research.

[51]  Y. Ke,et al.  Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. , 2008, Endocrinology.

[52]  M. Hentze,et al.  Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Núñez,et al.  Iron homeostasis in neuronal cells: a role for IREG1 , 2005, BMC Neuroscience.

[54]  S. Srai,et al.  Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells , 2007, Gut.

[55]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.